The United Kingdom (UK) introduced a series of price cuts in 2005 and an evaluation in 2007 suggested that the effects of the price cut are reduced over time and it is not clear whether the savings are temporary or long term.[17] It also noted that arbitrary price cuts may unfairly penalise drugs, which are already cost-effective or have already been subject to discounting.[18] The impact of furth